Introduction Atrial fibrillation (AF) cannot be considered an isolated disease. Patients with AF
should be managed using a comprehensive approach that is not limited to stroke …

Introduction In addition to an increased risk of thromboembolic complications, patients with
atrial fibrillation (AF) are at risk for vascular events. Consequently, complete vascular …

Aims To devise effective preventive measures, a profound understanding of the evolving
patterns and trends in atrial fibrillation (AF) and atrial flutter (AFL) burdens is pivotal. Our …

Landiolol is an ultra-short-acting, selective β1-adrenergic receptor blocker that was
originally approved in Japan for the treatment of intraoperative tachyarrhythmias. It has …

Atrial fibrillation and heart failure are two common cardiovascular conditions that frequently
coexist, and it has been widely demonstrated that in patients with chronic heart failure, atrial …

This article aims to analyze the relationship between non-obstructive coronary artery
disease (NOCAD) and atrial fibrillation (AF), exploring the underlying pathophysiological …

Introduction Chronic coronary syndrome (CCS) remains the leading cause of death
worldwide with high admission/re-admission rates. Medical databases were searched on …

Background This study aimed to describe the status of antithrombotic therapy at discharge
and prognosis in patients with atrial fibrillation (AF) and chronic coronary syndrome (CCS) …

Background Early diagnosis and continuity of care is vital for atrial fibrillation (AF), to reduce
stroke; There is a lack of understanding of when and how AF is being diagnosed and …

Background Early diagnosis and continuity of care is vital for atrial fibrillation (AF), to reduce
stroke; There is a lack of understanding of when and how AF is being diagnosed and …